Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.
- Published In:
- Cancers, 15(11) (2023)
- Authors:
- Merola, Elettra, Grana, Chiara Maria(2)
- Database ID:
- RPEP-07176
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07176APA
Merola, Elettra; Grana, Chiara Maria. (2023). Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.. Cancers, 15(11). https://doi.org/10.3390/cancers15112975
MLA
Merola, Elettra, et al. "Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.." Cancers, 2023. https://doi.org/10.3390/cancers15112975
RethinkPeptides
RethinkPeptides Research Database. "Peptide Receptor Radionuclide Therapy (PRRT): Innovations an..." RPEP-07176. Retrieved from https://rethinkpeptides.com/research/merola-2023-peptide-receptor-radionuclide-therapy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.